90 related articles for article (PubMed ID: 33193085)
1. Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such Patients.
Drozd V; Schneider R; Platonova T; Panasiuk G; Leonova T; Oculevich N; Shimanskaja I; Vershenya I; Dedovich T; Mitjukova T; Grelle I; Biko J; Reiners C
Front Endocrinol (Lausanne); 2020; 11():567385. PubMed ID: 33193085
[No Abstract] [Full Text] [Related]
2. Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study.
Piscopo L; Volpe F; Nappi C; Zampella E; Manganelli M; Matrisciano F; Totaro P; Pace L; Maurea S; Cuocolo A; Klain M
Curr Oncol; 2022 Dec; 30(1):37-44. PubMed ID: 36661652
[TBL] [Abstract][Full Text] [Related]
3. Hazard ratios of second primary malignancy after radioiodine for differentiated thyroid carcinoma: a large-cohort retrospective study.
Wu W; Li S; Xu K; Meng Z
Endokrynol Pol; 2023; 74(3):260-270. PubMed ID: 37335064
[TBL] [Abstract][Full Text] [Related]
4. Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.
Reinecke MJ; Ahlers G; Burchert A; Eilsberger F; Flux GD; Marlowe RJ; Mueller HH; Reiners C; Rohde F; van Santen HM; Luster M
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3247-3256. PubMed ID: 35320386
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors.
Bogdanova T; Rogounovitch TI; Zurnadzhy L; Mitsutake N; Tronko M; Ito M; Bolgov M; Chernyshov S; Gulevatyi S; Masiuk S; Yamashita S; Saenko VA
Front Endocrinol (Lausanne); 2023; 14():1343848. PubMed ID: 38260161
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Cancer After Chernobyl: Re-Evaluation Needed.
Jargin S
Turk Patoloji Derg; 2021; 37(1):1-6. PubMed ID: 32525210
[TBL] [Abstract][Full Text] [Related]
7. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
[TBL] [Abstract][Full Text] [Related]
8. The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer.
Demir AN; Kara Z; Sulu C; Uysal S; Zulfaliyeva G; Atar OA; Valikhanova N; Ozturk T; Ozkaya HM; Damci T; Gonen MS
Hormones (Athens); 2023 Dec; 22(4):595-602. PubMed ID: 37603221
[TBL] [Abstract][Full Text] [Related]
9. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract][Full Text] [Related]
10. Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer.
Kim KJ; Kim KJ; Choi J; Kim NH; Kim SG
J Natl Cancer Inst; 2023 Jun; 115(6):695-702. PubMed ID: 36821433
[TBL] [Abstract][Full Text] [Related]
11. The association between the interval of radioiodine treatment and treatment response, and side effects in patients with lung metastases from differentiated thyroid cancer.
Wang H; Shi L; Huang R; Liu B; Tian R
Front Endocrinol (Lausanne); 2023; 14():1117001. PubMed ID: 37324277
[TBL] [Abstract][Full Text] [Related]
12. Patterns of radioiodine use for differentiated thyroid carcinoma in Brazil: insights and a call for action from a 20-year database.
Schwengber WK; Mota LM; Nava CF; Rodrigues JAP; Zanella AB; De Souza Kuchenbecker R; Scheffel RS; Maia AL; Dora JM
Arch Endocrinol Metab; 2021 Nov; 64(6):824-832. PubMed ID: 33085995
[TBL] [Abstract][Full Text] [Related]
13. Effect of monocarboxylate transporter-1 on the biological behavior of iodine-refractory thyroid carcinoma.
Li Q; Xu B; Tang Y; Li Y; Ying H
Transl Cancer Res; 2021 Nov; 10(11):4914-4928. PubMed ID: 35116343
[TBL] [Abstract][Full Text] [Related]
14. Role of DNA Repair Variants and Diagnostic Radiology Exams in Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.
Zidane M; Truong T; Lesueur F; Xhaard C; Cordina-Duverger E; Boland A; Blanché H; Ory C; Chevillard S; Deleuze JF; Souchard V; Ren Y; Zemmache MZ; Canale S; Borson-Chazot F; Schvartz C; Mariné Barjoan E; Guizard AV; Laurent-Puig P; Mulot C; Guibon J; Karimi M; Schlumberger M; Adjadj E; Rubino C; Guenel P; Cazier JB; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1208-1217. PubMed ID: 33827984
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.
Tran TV; Rubino C; Allodji R; Andruccioli M; Bardet S; Diallo I; Dottorini M; Garsi J; Hall P; Henry-Amar M; Lamart S; Le Thai F; Lönn S; Ricard M; Schvartz C; Schlumberger M; Journy N; de Vathaire F
Br J Cancer; 2022 Dec; 127(12):2118-2124. PubMed ID: 36224404
[TBL] [Abstract][Full Text] [Related]
16. Second Primary Malignancy After Radioiodine Therapy in Thyroid Cancer Patient: A Nationwide Study.
Hong CM; Son J; Hyun MK; Lee JW; Lee J
Nucl Med Mol Imaging; 2023 Dec; 57(6):275-286. PubMed ID: 37982105
[TBL] [Abstract][Full Text] [Related]
17. Radiation Protection Considerations for Cancer Patients with End-stage Renal Disease Receiving 131 I Treatment.
Louis M; Mate-Kole EM; Aziz L; Dewji SA
Health Phys; 2024 Jan; 126(1):1-17. PubMed ID: 37792406
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Cancer after Exposure to Radioiodine in Childhood and Adolescence:
Zupunski L; Ostroumova E; Drozdovitch V; Veyalkin I; Ivanov V; Yamashita S; Cardis E; Kesminiene A
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31581656
[TBL] [Abstract][Full Text] [Related]
19. Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study.
Vallejo Casas JA; Sambo M; López López C; Durán-Poveda M; Rodríguez-Villanueva García J; Santos RJ; Llanos M; Navarro-González E; Aller J; Pubul V; Guadalix S; Crespo G; González C; Zafón C; Navarro M; Santamaría-Sandi J; Segura Á; Gajate P; Gómez-Balaguer M; Valdivia J; Puig-Domingo M; Galofré JC; Castelo B; Villanueva MJ; Argüelles I; Orcajo-Rincón L
Eur Thyroid J; 2022 Oct; 11(5):. PubMed ID: 35900793
[TBL] [Abstract][Full Text] [Related]
20. Simplified Assessment of Radioiodine Biokinetics for Thyroid Cancer Patients: A Practical Approach Using Continuous External Radiation Monitoring.
Tsai YK; Lin LF; Cheng CY; Wong CO; Wang WH; Shen DH; Su SL; Chen ES; Chen TY; Chen IF
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
